8-K: Stereotaxis, Inc. Announces Results of Annual Shareholder Meeting

Stereotaxis, Inc. held its Annual Meeting of Shareholders on May 15, 2025, and elected two Class III directors and ratified the appointment of Ernst & Young LLP as its independent registered public accounting firm for fiscal year 2025.

Summary

• Stereotaxis, Inc. held its Annual Meeting of Shareholders on May 15, 2025.
• A total of 85,979,662 shares of common stock were outstanding and entitled to vote, with Series A Convertible Preferred Stock entitled to an aggregate of 21,663,743 votes on an as-converted basis.
• 63,792,419 shares were represented at the meeting, constituting a 59% quorum.
• Shareholders elected Dr. Nathan Fischel and Mr. Ross B. Levin as Class III directors to serve until the 2028 Annual Meeting.
• The appointment of Ernst & Young LLP as the company's independent registered public accounting firm for fiscal year 2025 was ratified.

Sentiment

Score: 7

Explanation: The document reflects standard corporate governance procedures, indicating stability and routine operations. The sentiment is neutral to slightly positive.

Positives

• The election of directors ensures continuity and stability in the company's leadership.
• Ratification of Ernst & Young LLP as the independent auditor provides assurance of financial oversight and transparency.

Industry Context

This announcement is a routine corporate governance matter, typical for publicly traded companies.

Stakeholder Impact

• Shareholders have exercised their voting rights to elect directors and ratify the auditor.
• The election of directors ensures continued leadership and governance for the company.

Key Dates

Keywords

Annual Meeting, Shareholders, Directors, Ernst & Young, Proxy, Voting, Stereotaxis